Investigating the function of the OSM-OSMR axis in pancreatic ductal adenocarcinoma (PDAC)

被引：0
|
作者：
Sui, Yuan
Hunter, Tony
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6984
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6984
引用
收藏
页数：2
相关论文
共 50 条
  • [31] MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions
    Prinz, Christian
    Fehring, Leonard
    Frese, Robin
    CELLS, 2022, 11 (15)
  • [32] STATINS POTENTLY INHIBIT YAP FUNCTION AND PROLIFERATION OF PANCREATIC DUCTAL ADENOCARCINOMA CANCER (PDAC) CELLS
    Hao, Fang
    Xu, Qinhong
    Zhao, Yinglan
    Sinnett-Smith, James
    Young, Steven H.
    Stevens, Jan V.
    Rozengurt, Enrique
    GASTROENTEROLOGY, 2017, 152 (05) : S837 - S838
  • [33] Investigating mechanical phenotype in pancreatic ductal adenocarcinoma
    Nguyen, A. V.
    Scott, M. B.
    Nguyen, A. H.
    Wu, N.
    Donahue, T. R.
    Rowat, A. C.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [34] PIK3CA mutations in pancreatic ductal adenocarcinoma (PDAC)
    Pitiyarachchi, O.
    Sim, H-W.
    ANNALS OF ONCOLOGY, 2024, 35 : S1499 - S1499
  • [35] Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)
    Pitiyarachchi, O.
    Lin, F. P.
    Spooner, A.
    Sharbeen, G.
    Barker, H. P.
    Thornton, K.
    Collignon, E.
    Ballinger, M. L.
    Thomas, D. M.
    Magenau, A.
    Porazinski, S.
    Raina, A.
    Sjoquist, K. M.
    Chantrill, L. A.
    Gebski, V.
    Sowmya, A.
    Timpson, P.
    Pajic, M.
    Goldstein, D.
    Phillips, P. A.
    ANNALS OF ONCOLOGY, 2024, 35 : S925 - S925
  • [36] Argyrin F therapy attenuates carcinogenesis of pancreatic ductal adenocarcinoma (PDAC)
    Barat, S.
    Xi, C.
    Bozko, P.
    Bui, K. C.
    Sipos, B.
    Kalesse, M.
    Malek, N. P.
    Plentz, R. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 11 - 11
  • [37] Prediction of response to pelareorep plus pembrolizumab in pancreatic ductal adenocarcinoma (PDAC).
    Fountzilas, Christos
    Wilkinson, Grey A.
    Eng, Kevin H.
    Fields, Paul
    Arora, Sukeshi Patel
    Kalinski, Pawel
    Raber, Patrick
    Nuovo, Gerard
    Coffey, Matthew C.
    Mahalingam, Devalingam
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Clinicopathologic Characteristics and Biologic Behavior of Concurrent Pancreatic Ductal Adenocarcinoma (PDAC)
    Lew, M.
    Morales-Oyarvide, V.
    Liao, X.
    Ogino, S.
    Chen, J-H
    Pitman, M. B.
    Mino-Kenudson, M.
    MODERN PATHOLOGY, 2012, 25 : 446A - 446A
  • [39] Clinical impact of visceral thrombosis (VT) in pancreatic ductal adenocarcinoma (PDAC).
    Hicks, Angel Mier
    Raj, Micheal
    Do, Richard Kinh Gian
    Yu, Kenneth H.
    Lowery, Maeve Aine
    Varghese, Anna M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [40] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
12345